[{"orgOrder":0,"company":"Wagner Macula & Retina Center","sponsor":"Oxurion","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Eplerenone","moa":"Mineralocorticoid receptor","graph1":"Ophthalmology","graph2":"Phase II","graph3":"Wagner Macula & Retina Center","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Intravitreal","sponsorNew":"Wagner Macula & Retina Center \/ Oxurion","highestDevelopmentStatusID":"8","companyTruncated":"Wagner Macula & Retina Center \/ Oxurion"},{"orgOrder":0,"company":"NHS National Waiting Times Centre Board","sponsor":"British Heart Foundation | Abbott Laboratories","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Eplerenone","moa":"Mineralocorticoid receptor","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase II","graph3":"NHS National Waiting Times Centre Board","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"NHS National Waiting Times Centre Board \/ British Heart Foundation | Abbott Laboratories","highestDevelopmentStatusID":"8","companyTruncated":"NHS National Waiting Times Centre Board \/ British Heart Foundation | Abbott Laboratories"},{"orgOrder":0,"company":"Darnitsa","sponsor":"ACDIMA Biocenter","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UKRAINE","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Eplerenone","moa":"Mineralocorticoid receptor","graph1":"Undisclosed","graph2":"Phase I","graph3":"Darnitsa","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Oral Tablet, Film Coated","sponsorNew":"Darnitsa \/ ACDIMA Biocenter","highestDevelopmentStatusID":"6","companyTruncated":"Darnitsa \/ ACDIMA Biocenter"}]

Find Clinical Drug Pipeline Developments & Deals for Eplerenone

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Darnitsa

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Darnitsa

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          December 23, 2022

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I

                          Sponsor : ACDIMA Biocenter

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          NHS National Waiting Times Centre Board

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          NHS National Waiting Times Centre Board

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          January 20, 2022

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase II

                          Sponsor : British Heart Foundation | Abbott Laboratories

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Wagner Macula & Retina Center

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Wagner Macula & Retina Center

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 09, 2020

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Ophthalmology

                          Highest Development Status : Phase II

                          Sponsor : Oxurion

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Biolab Sanus Farmaceutica

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Biolab Sanus Farmaceutica

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          November 06, 2016

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Biolab Sanus Farmaceutica

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Biolab Sanus Farmaceutica

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          November 18, 2015

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Bayside Health

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Bayside Health

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          January 26, 2015

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase IV

                          Sponsor : Baker Heart and Diabetes Institute

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          CPHI Shenzhen
                          Not Confirmed
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          October 29, 2013

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase IV

                          Sponsor : Pfizer Inc

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          M.p. van den Berg, MD, PhD, professor in Cardiology

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          M.p. van den Berg, MD, PhD, professor in Cardiology

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Study Phase : Phase III

                          Sponsor : University Medical Center Groningen | The Interuniversity Cardiology Institute of the Netherlands | ZonMw | Netherlands: CVON, CardioVascular Research Netherlands

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          May 20, 2013

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase III

                          Sponsor : University Medical Center Groningen | The Interuniversity Cardiology Institute of the Netherlands | ZonMw | Netherlands: CVON, CardioVascular Research Netherlands

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          University of British Columbia

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          University of British Columbia

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          October 17, 2012

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Canadian Cancer Society | Pfizer Inc

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          Montreal Heart Institute

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Montreal Heart Institute

                          Country arrow
                          CPHI Shenzhen
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          April 26, 2012

                          Lead Product(s) : Eplerenone

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase III

                          Sponsor : Pfizer Inc

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank